For the millions of adults managing hypertension without optimal pharmacological control, exercise remains an underutilized clinical tool — and understanding exactly which exercise protocols produce the most meaningful blood pressure reductions could reshape how clinicians prescribe movement as medicine. A bibliometric analysis spanning four decades now offers the clearest panoramic view yet of where this science stands and where its most productive frontiers lie.

Analyzing metadata from 440 peer-reviewed articles published between 1985 and 2024, researchers mapped the intellectual architecture of post-exercise hypotension (PEH) research using keyword co-occurrence network software. The analysis identified high-intensity interval training (HIIT), isometric resistance exercise, and nutritional co-interventions as the field's most rapidly expanding research clusters. Brazil and the United States dominated publication output. Findings consistently implicated autonomic nervous system modulation and vascular adaptations as the primary physiological mechanisms governing the magnitude and duration of the post-exercise blood pressure dip, with recovery posture and exercise intensity identified as meaningful modulators.

Bibliometric studies are maps, not experiments — they reveal the shape of a scientific conversation without adjudicating which findings are correct. That said, this particular map is analytically valuable. The identification of isometric resistance exercise as an emerging focus aligns with recent meta-analytic evidence suggesting isometric protocols may produce disproportionately large chronic blood pressure reductions relative to their volume, a finding that has attracted considerable attention since a 2023 British Journal of Sports Medicine meta-analysis ranked isometric training above other modalities. The convergence of nutritional and exercise strategies as a joint research frontier is also notable: combining dietary nitrates or polyphenols with structured exercise may amplify PEH through complementary vasodilatory pathways. Key limitations flagged by the authors — lack of standardized assessment protocols and sparse biomarker integration — are genuine obstacles to clinical translation. This review is best read as a research agenda rather than a clinical guideline, but its precision in locating gaps makes it a useful navigational tool for practitioners and researchers alike.